Home > Healthcare > Medical Devices > Surgical Devices > Intracranial Aneurysm Market

Intracranial Aneurysm Market Share

Report ID: GMI7061
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Intracranial Aneurysm Market Share

The intracranial aneurysm industry is fairly consolidated in nature, with major companies competing to offer superior intracranial aneurysm in this business space. Prominent players such as Medtronic, Stryker, and Johnson & Johnson Services, Inc. hold a significant share in this market. These companies are diligently directing their efforts towards continuous treatment type innovation to gain substantial market share.

Some of the eminent market participants operating in the intracranial aneurysm industry include:

Medtronic
Stryker
MicroPort Scientific Corporation
Johnson & Johnson Services, Inc.
MicroVention Inc.
Integra LifeSciences
B. Braun Melsungen AG
Delta Surgical
Mizuho Medical Co. Ltd.
Penumbra, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global intracranial aneurysm industry was valued at USD 1.2 billion in 2022 and is estimated to reach USD 2.7 billion by 2032, backed by the global aging population.

The endovascular coiling segment garnered USD 854.7 million in 2022 and will keep growing as this treatment is a less invasive alternative to traditional surgical clipping, alongside is associated with better patient outcomes in certain cases.

North America intracranial aneurysm market accounted for USD 433.8 million in 2022 and is predicted to witness substantial growth as the region has a significant burden of intracranial aneurysms, partly due to lifestyle factors like smoking and hypertension.

Medtronic, Stryker, MicroPort Scientific Corporation, Johnson & Johnson Services, Inc., MicroVention Inc., Integra LifeSciences, and B. Braun Melsungen AG among others.